Abstract
We propose and implement a novel approach to model the evolution of COVID-19 pandemic and predict the daily COVID-19 cases (infected, recovered and dead). Our model builds on the classical SEIR-based framework by adding additional compartments to capture recovered, dead and quarantined cases. Quarantine impacts are modeled using an Artificial Neural Network (ANN), leveraging alternative data sources such as the Google mobility reports. Since our model captures the impact of lockdown policies through the quarantine functions we designed, it is able to model and predict future waves of COVID-19 cases. We also benchmark out-of-sample predictions from our model versus those from other popular COVID-19 case projection models.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This paper was not funded by anyone (person, group or legal entity) and it is self-motivated by authors. The authors are from Quantitative Advisory Services at Ernst & Young US LLP. The authors alone are responsible for the content and writing of this paper. The information and views expressed by the authors are their own and not those of Ernst & Young LLP or other member firms of the global EY organization.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵† mencius72{at}gmail.com
Data Availability
All data produced in the present study are available upon reasonable request to the authors
